Icahn School of Medicine at Mount Sinai Researchers Target Autism (Protein-truncating variants and deletions of SHANK2 are associated with autism spectrum disorder and other neurodevelopmental concerns)

Press/Media

Period	19 May 2025

Media coverage

Title	Icahn School of Medicine at Mount Sinai Researchers Target Autism (Protein-truncating variants and deletions of SHANK2 are associated with autism spectrum disorder and other neurodevelopmental concerns)
Media name/outlet	Clinical Trials Daily
Country/Territory	United States
Date	19/05/25
Persons	Alexander Kolevzon, Jessica Zweifach, Dorothy Grice, Joseph Buxbaum, Latha Soorya, Tess Levy